Urokinase Pregnancy and Breastfeeding Warnings
Urokinase is also known as: Abbokinase, Abbokinase Open-Cath, Kinlytic
Medically reviewed on March 3, 2017
Urokinase Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: B
Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Urokinase Breastfeeding Warnings
Caution is recommended; some authorities recommend avoiding breastfeeding during use of this drug.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
References for pregnancy information
- "Product Information. Kinlytic (urokinase)." ImaRx Therapeutics, Inc, Tucson,, AR.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
References for breastfeeding information
- "Product Information. Kinlytic (urokinase)." ImaRx Therapeutics, Inc, Tucson,, AR.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
See Also...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
